Pediatric Neuromuscular Disorders

Paediatric neuromuscular disorders are conditions of the motor nerve cells, nerves, neuromuscular junction or muscles that begin in infancy or childhood. Most are genetic. The commonest are Duchenne muscular dystrophy and spinal muscular atrophy (SMA).

The field has changed fast. SMA now has three disease-modifying treatments that work best when given before or soon after symptoms begin, and Duchenne care standards have added years of walking and of life. Early diagnosis is therefore critical.

Conditions this service looks after

• Spinal muscular atrophy
• Duchenne and Becker muscular dystrophy
• Congenital muscular dystrophies and myopathies
• Limb-girdle muscular dystrophies
• Charcot-Marie-Tooth disease
• Congenital myasthenic syndromes and juvenile myasthenia gravis
• Myotonic dystrophy
• Juvenile dermatomyositis

Tests you may be offered

• Clinical examination: Signs include a floppy infant, late walking, Gowers' sign, toe walking and enlarged calves.
• Creatine kinase (CK): Very high levels in a boy with motor delay point to Duchenne dystrophy.
• Genetic testing: SMN1 testing for SMA gives results within days to weeks; dystrophin gene analysis and myopathy panels for others.
• EMG and nerve conduction: Adapted for children when genetics are inconclusive.
• Muscle MRI and biopsy: For unresolved cases.
• Heart, lung and sleep assessment: Echocardiogram or cardiac MRI, spirometry and sleep studies, repeated regularly.

Treatments available

• SMA therapies: Nusinersen by lumbar puncture every 4 months, daily oral risdiplam, or a single gene replacement infusion in young children; eligibility rules and funding vary by country.
• Corticosteroids for Duchenne: Prolong walking and protect heart and lung function, with monitoring of bones and growth.
• Mutation-specific Duchenne treatments: Exon-skipping drugs and newer agents apply to defined mutations, with modest benefits so far.
• Respiratory care: Cough assistance, vaccinations and night-time non-invasive ventilation.
• Cardiac care: Heart-protective medication started early.
• Orthopaedic and rehabilitation care: Stretching, orthoses, scoliosis monitoring and spinal surgery when necessary.
• Immunotherapy: For juvenile myasthenia and dermatomyositis.

When to ask for a specialist opinion

• A baby who is floppy, feeds poorly or has a weak cry
• A boy not walking by 18 months, or who struggles to rise from the floor
• Frequent falls, toe walking or difficulty with stairs
• A raised CK or unexplained raised liver enzymes (ALT and AST can originate from muscle)
• A family history of muscle disease

Travelling to Türkiye for this care

A diagnostic visit with genetic testing and heart and lung baseline checks is feasible in 3 to 5 days. High-cost SMA and Duchenne therapies need formal eligibility assessment, long-term safety monitoring and secured funding, so discuss with your home team how continuing doses would be delivered before starting abroad. Weak infants may not be fit to fly; ask for medical advice first.

Send your reports, scans and a short history and a Clinic-Y coordinator replies within 24 hours with suitable teams and written, all-inclusive proposals side by side. Reviewing your case is free.

الأسئلة المتكررة